ATAI
ATAI Life Sciences BV
NASDAQ: ATAI · HEALTHCARE · BIOTECHNOLOGY
$4.12
-4.85% today
Updated 2026-04-29
Market cap
$1.51B
P/E ratio
—
P/S ratio
369.70x
EPS (TTM)
$-2.91
Dividend yield
—
52W range
$1 – $7
Volume
6.2M
ATAI Life Sciences BV (ATAI) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-7.85M | $-20.77M | $-63.25M | $-104.47M | $-84.12M | $-82.44M | $-102.67M |
| Capital expenditures | $19000.00 | $59000.00 | $1.13M | $1.02M | $590000.00 | $95000.00 | $901000.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $57000.00 | $67.16M | $63.36M | $42.38M | $32.98M | $25.49M | $14.21M |
| Free cash flow | $-7.87M | $-20.82M | $-64.37M | $-105.49M | $-84.71M | $-82.53M | $-103.58M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-170.53M | — | — | — |